menu
    • menu

    Company profile for Ayala Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs...
    Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ayala PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1313 N. Market Steet, Suite 5100 Wilmington, DE 19801, USA
    Telephone
    Telephone
    +1-857-444-0553
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ayalapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OS Therapies Acquires Advaxis Immuno Assets from Ayala Pharma
    OS Therapies Acquires Advaxis Immuno Assets from Ayala Pharma

    09 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250409331328/en/OS-Therapies-Completes-Acquisition-of-Advaxis-Immunotherapies-Clinical-Pre-clinical-and-IP-Assets-from-Ayala-Pharmaceuticals

    BUSINESSWIRE
    09 Apr 2025
    Share Share
    OS Therapies Acquires Ayala’s Listeria Immuno-Oncology Assets
    OS Therapies Acquires Ayala’s Listeria Immuno-Oncology Assets

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129509280/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    Ayala Pharma To Deregister And Suspend Reporting Obligations
    Ayala Pharma To Deregister And Suspend Reporting Obligations

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2879215/0/en/Ayala-Pharmaceuticals-Files-Form-15-to-Voluntarily-Deregister-and-Suspend-its-Reporting-Obligations.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Immunome Completes Acquisition of AL102 From Ayala
    Immunome Completes Acquisition of AL102 From Ayala

    26 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240326907197/en

    BUSINESSWIRE
    26 Mar 2024
    Share Share
    Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
    Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

    26 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/26/2852273/0/en/Ayala-Pharmaceuticals-Announces-Completion-of-Sale-of-AL102-to-Immunome.html

    GLOBENEWSWIRE
    26 Mar 2024
    Share Share
    Ayala Announces Completion of Enrollment in Phase 3 Study Evaluating AL102
    Ayala Announces Completion of Enrollment in Phase 3 Study Evaluating AL102

    20 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/20/2831772/0/en/Ayala-Pharmaceuticals-Announces-Completion-of-Enrollment-in-Phase-3-RINGSIDE-Study-Evaluating-AL102-in-Desmoid-Tumors.html

    GLOBENEWSWIRE
    20 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search